Black Bird Biotech, Inc. (BBBT) Research

Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.

Market snapshot

Symbol
BBBT
Price
$0.00
Day change
0.00%
Market cap
$98.4K
P/E ratio
-0.02x
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Advantis Corp. (ADVT)
  • CannLabs, Inc. (CANL)
  • Parallel Industries Inc. (EAPH)
  • The Greater Cannabis Company, Inc. (GCAN)
  • Green Rain Energy Holdings Inc. (GREH)
  • Novo Integrated Sciences, Inc. (NVOS)
  • Panbela Therapeutics, Inc. (PBLA)
  • Street Capital Inc. (REZNF)

Recent insider activity

  • Collins Jeffrey A — trade (0 shares) on 2009-01-15

Open Black Bird Biotech, Inc. (BBBT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.